"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
MedPage Today on MSN1d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...
Dallas Morning News on MSN5d
FDA adds new warning to weight loss drugs including WegovyThe FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Medpage Today on MSN5d
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 YearsSAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says. GLP-1 weight ...
A mixed sales report for Novo Nordisk’s GLP-1 megablockbuster drugs failed to quiet concerns Wednesday that investors may ...
Nov. 12, 2024 – Most people taking GLP-1 drugs for weight loss or diabetes no longer need to stop taking them before elective surgery, according to new guidance from the American Society of ...
India Today on MSN1d
Popular weight-loss drugs trigger muscle loss: Lancet study findsA Lancet study suggests that popular weight loss drugs could lead to muscle loss. Reserachers recommend combining these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback